Standard Document

Fourth Edition

Microbiology

CLSI M38M51S

Performance Standards for Antifungal Susceptibility Testing of Filamentous Fungi

CLSI M38M51S includes minimal inhibitory concentration breakpoints and quality control tables for the Clinical and Laboratory Standards Institute antifungal susceptibility testing documents CLSI M38 and CLSI M51.

Date of Publication March 04, 2026

Chairholder Philippe Dufresne, PhD; Nathan Wiederhold, PharmD

Free

{{FormatPrice(nonMemberPrice)}} List Price

This is your member pricing.

Notify Me About New Editions

Abstract

CLSI M38M51S—Performance Standards for Antifungal Susceptibility Testing of Filamentous Fungi includes minimal inhibitory concentration and quality control tables developed following the guidance in CLSI M381 and CLSI M51. The data in the tables are valid only when the methodologies in CLSI M38 and CLSI M51 are followed. Users should replace previously published tables with these new tables. Changes in the tables since the previous edition was published appear in boldface type.

Product Details

PDF Code M38M51SEd4E

PDF ISBN 978-1-68440-314-1

Pages 24

Additional Details

This document is available in electronic format only.

Authors

Philippe J. Dufresne, PhD

Nathan P. Wiederhold, PharmD

Barbara D. Alexander, MD, MHS

David Andes, MD

Andrew Borman, BSc, PhD

Ryan Demkowicz, MD

Tanis Dingle, PhD, D(ABMM), FCCM

Hari Dwivedi, BVSc(DVM), MVSC, PhD

Julianne Kus, MSc, PhD, FCCM

Shawn R. Lockhart, PhD, D(ABMM), F(AAM)

Stephanie Mitchell, PhD, D(ABMM)

Chris Pillar, PhD

Amir Seyedmousavi, VMD, PhD, D(ABMM), FECMM

Paul E. Verweij, MD, FECMM

Sean Zhang, MD, PhD, D(ABMM)